CHEMLINE ARC SG FR PART A

Hazard statements (CLP)

H303, H315, H317, H319, H334, H336, H351

Code

Statements

H303

May be harmful if swallowed

SECTION 2: Hazards identification

Classification of the Substance or Mixture

Signal word

DANGER

Hazard statements

H303 - May be harmful if swallowed H315 - Causes skin irritation H319 - Causes serious eye irritation H334 - May cause allergy or asthma symptoms of breathing difficulties if inhaled H317 - May cause an allergic skin reaction H351 - Suspected of causing cancer. H336 - May cause drowsiness or dizziness

Precautionary statements

P260 - Do not breathe dust/ fume/ gas/ mist/ vapours/ spray. P264 - Wash skin thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P273 - Avoid release to the environment. P280 - Wear protective gloves. P284 - Wear respiratory protection. P301 + P312 - IF SWALLOWED: Call a POISON CENTER or doctor/ physician if you feel unwell. P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 - Immediately call a POISON CENTER or doctor/ physician. P330 - Rinse mouth. P501 - Dispose of contents/ container to an approved waste disposal plant.

Principle Routes of Exposure

Target Organs Inhalation Eyes; Ingestion; Inhalation; Skin; Respiratory system; Skin; Eyes; At room temperature, MDI vapors are minimal due to low vapor pressure. However, heating, spraying, foaming, or otherwise mechanically dispersing (drumming, venting or pumping) operations may generate vapor or aerosol concentrations sufficient to cause irritation or other adverse effects. Excessive exposure may cause irritation of the eyes, upper respiratory tract and lungs. Severe overexposure may lead to pulmonary edema. May cause respiratory sensitization with asthma-like symptoms in susceptible individuals. MDI concentrations below the exposure guidelines may cause allergic respiratory reactions in individuals already sensitized. Symptoms may include coughing, dryness of throat, headache, nausea, difficult breathing and a feeling of tightness in the chest. Effects may be delayed. Impaired lung function (decreased ventilator capacity) has been associated with overexposure to isocyanates Chronic: As a result of previous repeated overexposures or a single large dose, certain individuals develop isocyanate sensitization (chemical asthma) or tissue injury in the upper respiratory tract. Animal tests indicate skin contact alone may also lead to allergic respiratory reaction. These effects may be permanent. Any person developing asthmatic reaction or other sensitization should be removed from further exposure Skin Contact Isocyanates react with skin protein and moisture and can cause irritation which may include the following symptoms: reddening, swelling, rash, scaling or blistering. Cured material is difficult to remove. Prolonged or repeated exposure can cause skin irritation, reddening, dermatitis, and in some individuals, sensitization. Skin contact may result in allergic skin reactions or respiratory sensitization, but is not expected to result in absorption of amounts sufficient to cause other adverse effects. May stain skin. Eye Contact As a liquid or dust, may cause irritation, inflammation, and/or damage to sensitive eye tissue. Symptoms include watering or discomfort of the eyes. Ingestion Single dose oral toxicity is considered to be extremely low. Can result in irritation and corrosive action in the mouth, stomach tissue and digestive tract. Ingestion is not an applicable route of entry for intended use.

2.1 Classification of the substance or mixture

GHS Classification in Accordance with 29 CFR 1910 (OSHA HCS): Health, Acute toxicity, 5 Oral Health, Skin corrosion/irritation, 2 Health, Serious Eye Damage/Eye Irritation, 2 A Health, Respiratory or skin sensitization, 1 Respiratory Health, Respiratory or skin sensitization, 1 Skin Health, Carcinogenicity, 2 Health, Specific target organ toxicity - Single exposure, 3